View in EDS

Impact of less invasive axillary staging procedures after neoadjuvant systemic therapy on adjuvant systemic therapy indications in HER2-positive and triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: Impact of less invasive axillary staging procedures after neoadjuvant systemic therapy on adjuvant systemic therapy indications in HER2-positive and triple-negative breast cancer.
Authors: Claassens EL; Department of Surgery, Maastricht University Medical Centre+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands. Electronic address: eva.claassens@maastrichtuniversity.nl., Koppert LB; Department of Surgical Oncology, Erasmus Medical Centre Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands., van der Pol CC; Department of Surgical Oncology, Cancer Centre, University Medical Centre Utrecht, Utrecht, the Netherlands; Department of Surgical Oncology, Alrijne Hospital, Leiderdorp, the Netherlands., Luiten EJT; Department of Surgical Oncology, Amphia Hospital, Breda, the Netherlands; Department of Surgery College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi Emirate, United Arab Emirates., van Nijnatten TJA; GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, Maastricht, the Netherlands., Jager A; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands., de Boer M; Division of Medical Oncology, Department of Internal Medicine, GROW - Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands., van Diest PJ; Department of Pathology, University Medical Centre Utrecht, Utrecht, the Netherlands., Smidt ML; Department of Surgery, Maastricht University Medical Centre+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands., Simons JM; GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands; Department of Radiotherapy, Erasmus Medical Centre Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands.
Corporate Authors: RISAS study group
Source: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2026 Jun; Vol. 52 (6), pp. 111785. Date of Electronic Publication: 2026 Apr 03.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2157 (Electronic) Linking ISSN: 07487983 NLM ISO Abbreviation: Eur J Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42000404
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of less invasive axillary staging procedures after neoadjuvant systemic therapy on adjuvant systemic therapy indications in HER2-positive and triple-negative breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Claassens+EL%22">Claassens EL</searchLink>; Department of Surgery, Maastricht University Medical Centre+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands. Electronic address: eva.claassens@maastrichtuniversity.nl.<br /><searchLink fieldCode="AU" term="%22Koppert+LB%22">Koppert LB</searchLink>; Department of Surgical Oncology, Erasmus Medical Centre Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Pol+CC%22">van der Pol CC</searchLink>; Department of Surgical Oncology, Cancer Centre, University Medical Centre Utrecht, Utrecht, the Netherlands; Department of Surgical Oncology, Alrijne Hospital, Leiderdorp, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Luiten+EJT%22">Luiten EJT</searchLink>; Department of Surgical Oncology, Amphia Hospital, Breda, the Netherlands; Department of Surgery College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi Emirate, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22van+Nijnatten+TJA%22">van Nijnatten TJA</searchLink>; GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, Maastricht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Jager+A%22">Jager A</searchLink>; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Boer+M%22">de Boer M</searchLink>; Division of Medical Oncology, Department of Internal Medicine, GROW - Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Diest+PJ%22">van Diest PJ</searchLink>; Department of Pathology, University Medical Centre Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Smidt+ML%22">Smidt ML</searchLink>; Department of Surgery, Maastricht University Medical Centre+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Simons+JM%22">Simons JM</searchLink>; GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands; Department of Radiotherapy, Erasmus Medical Centre Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22RISAS+study+group%22">RISAS study group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228504356%22">European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</searchLink> [Eur J Surg Oncol] 2026 Jun; Vol. 52 (6), pp. 111785. <i>Date of Electronic Publication: </i>2026 Apr 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8504356 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-2157 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2207487983%22">07487983 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Surg Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42000404
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejso.2026.111785
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 111785
    Titles:
      – TitleFull: Impact of less invasive axillary staging procedures after neoadjuvant systemic therapy on adjuvant systemic therapy indications in HER2-positive and triple-negative breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Claassens EL
      – PersonEntity:
          Name:
            NameFull: Koppert LB
      – PersonEntity:
          Name:
            NameFull: van der Pol CC
      – PersonEntity:
          Name:
            NameFull: Luiten EJT
      – PersonEntity:
          Name:
            NameFull: van Nijnatten TJA
      – PersonEntity:
          Name:
            NameFull: Jager A
      – PersonEntity:
          Name:
            NameFull: de Boer M
      – PersonEntity:
          Name:
            NameFull: van Diest PJ
      – PersonEntity:
          Name:
            NameFull: Smidt ML
      – PersonEntity:
          Name:
            NameFull: Simons JM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1532-2157
          Numbering:
            – Type: volume
              Value: 52
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
              Type: main
ResultId 1